Articles From: Prologis Signs Build-to-Suit Agreements in the Czech Republic and Germany to ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2014


SAN FRANCISCO , Sept.
Sign-up for Prologis Signs Build-to-Suit Agreements in the Czech Republic and Germany investment picks
SAN FRANCISCO , Oct.
Sign-up for Prologis to Announce Third Quarter 2014 Results on October 23 investment picks
SAN FRANCISCO , Sept.
Sign-up for Prologis to Host Investor/Analyst Event investment picks
SAN FRANCISCO , Oct.
Sign-up for Prologis to Present at ISI 2014 Real Estate Conference investment picks
SAN FRANCISCO , Oct.
Sign-up for Prologis, L.P. Prices Euro 600 million of Guaranteed Notes due 2020 investment picks
2014/11/20
Weakness in Energy Prices is Good Deflation, Due to Successful Technological Innovation NEW YORK and LONDON , Nov.
Sign-up for Prolonged Global and U.S. Economic Expansion Expected, Says BNY Mellon's Richard Hoey investment picks
2014/11/4
Global education technology leader Promethean today announced its signature of the Student Privacy Pledge, demonstrating its commitment to responsibly handling students’ personal information and data.
Sign-up for Promethean Pledges to Safeguard Student Privacy investment picks
ProMetic Announces $25.1 Million Bought Deal Offering to Fund Strategic Growth Initiatives Canada NewsWire NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES LAVAL, QC , Nov.
Sign-up for ProMetic Announces $25.1 Million Bought Deal Offering to Fund Strategic Growth Initiatives investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983125001&sourceType=1 http://media3.marketwire.com/docs/ProMetic_new_200.jpg LAVAL, QUEBEC --
Sign-up for ProMetic Announces Closing of Bought Deal Offering of Common Shares investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983801001&sourceType=1 http://media3.marketwire.com/docs/ProMetic_new_200.jpg LAVAL, QUEBEC --
Sign-up for ProMetic Announces the Exercise of the Over-Allotment Option Under its Bought Deal Offering of Common Shares investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978943001&sourceType=1 http://media3.marketwire.com/docs/ProMetic_new_200.jpg LAVAL, QUEBEC --
Sign-up for ProMetic Reports its Third Quarter 2014 Highlights and Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0968117001&sourceType=1 http://www.ccnmatthews.com/logos/20051018-prometic.gif LAVAL, QUEBEC --
Sign-up for ProMetic to Be Added to S&P/TSX SmallCap Index investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0975061001&sourceType=1 http://www.ccnmatthews.com/logos/20051018-prometic.gif LAVAL, QUEBEC --
Sign-up for ProMetic to Hold a Plasminogen Update Conference Call/Webcast investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977836001&sourceType=1 http://www.ccnmatthews.com/logos/20051018-prometic.gif LAVAL, QUEBEC --
Sign-up for ProMetic to Report its Third Quarter 2014 Financial Results and Hold Conference Call / Webcast investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978263001&sourceType=1 http://www.ccnmatthews.com/logos/20051018-prometic.gif LAVAL, QUEBEC --
Sign-up for ProMetic's PBI-4050 Cleared to Commence Clinical Trials in Patients with Diabetic Kidney Disease investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0972967001&sourceType=1 http://www.ccnmatthews.com/logos/20051018-prometic.gif LAVAL, QUEBEC --
Sign-up for ProMetic's PBI-4050 to Target Idiopathic Pulmonary Fibrosis ("IPF") as One of Its Orphan Indications investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0975102001&sourceType=1 http://www.ccnmatthews.com/logos/20051018-prometic.gif ROCKVILLE, MARYLAND and LAVAL, QUEBEC --
Sign-up for ProMetic's Plasminogen IND and Clinical Program Cleared by FDA investment picks
http://media.marketwire.com/attachments/201404/243780_Peregrine_logo_CMYK_sanspharm.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155133&ProfileId=051205&sourceType=1 TUSTIN, CA --
Sign-up for Promising Data Presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology From an Investigator-Sponsored Trial of Peregrine Pharmaceuticals' Bavituximab in Combination With Pemetrexed and Carboplatin in Front-Line Non-Small Cell Lung Cancer investment picks
http://media.marketwire.com/attachments/201111/36609_proofpoint.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153701&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Proofpoint Announces Third Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201111/36609_proofpoint.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1161097&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Proofpoint Enterprise Governance Recognized for Excellence With 2014 Third-Party Reader's Choice Award From Redmond Magazine investment picks
http://media.marketwire.com/attachments/201111/36609_proofpoint.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158622&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Proofpoint Ranked Number 410 Fastest Growing Company in North America on Deloitte's 2014 Technology Fast 500(TM) investment picks
http://media.marketwire.com/attachments/201111/36609_proofpoint.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153731&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Proofpoint Signs Definitive Agreement to Acquire Nexgate, Enters Social Media Security and Compliance Market investment picks
http://media.marketwire.com/attachments/201111/36609_proofpoint.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1161472&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Proofpoint to Present at Credit Suisse Technology Conference investment picks
http://media.marketwire.com/attachments/201111/36609_proofpoint.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155592&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Proofpoint to Present at Upcoming Conferences investment picks
http://media.marketwire.com/attachments/201111/36609_proofpoint.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159113&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Proofpoint to Present at Upcoming WOMMA Summit and Enterprise Security and Risk Management 2014 investment picks
http://media.marketwire.com/attachments/201111/36609_proofpoint.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1149942&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Proofpoint to Report Third Quarter 2014 Financial Results investment picks
2014/9/17
Lower fees will help more Texans resolve overdue property taxes AUSTIN, Texas , Sept.
Sign-up for Propel Financial Services Urges 75% Lower Closing Cost Limits on Tax Lien Transfers investment picks
2014/11/25
SYDNEY , Nov.
Sign-up for Property Exchange Australia Chooses Verizon to Secure Online Property Transactions investment picks
Low Losses and New Capital Sources Fuel Downward Pressure on Property Market; Easing of Upward Pressure on Casualty Market NEW YORK, Oct.
Sign-up for Property/Casualty Insurance Marketplace Experiences Further Softening: Willis Report investment picks
http://media.marketwire.com/attachments/201105/63802_ProPhaseLabsLogo.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158486&ProfileId=051205&sourceType=1 DOYLESTOWN, PA --
Sign-up for ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2014 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Prologis Signs Build-to-Suit Agreements in the Czech Republic and Germany to ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent